Shanghai Medical and Pharmaceutical Journal 2013 Issue 19 gan xi bao liao fa chan pin de fa zhan xian zhuang yan fa jin zhan ji shi chang zhan wang

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Shanghai Medical and Pharmaceutical Journal
1006-1533
2013 Issue 19

gan xi bao liao fa chan pin de fa zhan xian zhuang yan fa jin zhan ji shi chang zhan wang
ma pei qi

..............page:58-60

Focus on adverse drug reactions caused by different metabolic processes
FANG Yu;ZHU Deqiu

..............page:19-21

chuan bo nao ke xue cu jin nao jian kang --2013 nian nao jian kang gong yi xuan jiao huo dong cheng gong ju ban

..............page:13-13

Evaluation of the dissolution consistency of silymarin capsules
HUA Yudong;LIU Yanlong;LIU Juan

..............page:38-42,43

shang hai yi yao za zhi ying xiang yin zi da 0.794 jiao shang nian sheng gao 10.3%

..............page:35-35

Comparison and analysis of regulations on orphan drugs in several countries and regions
GAN Jue;XU Shanping;CHEN Yongfa;HU Tingxi

..............page:27-31

xin yi er chang cong si xiao mie yi bao zheng dao liang hua rong he pai tou bing

..............page:1-2

cfda fa bu shi shi yao wu lin chuang shi yan deng ji yu xin xi gong shi

..............page:9-9

Recent progress in research and development of bronchodilators for the treatment of COPD and their situation on market
ZHANG Jianzhong;KE Ying;SHEN Jialin

..............page:50-54,55

shang hai yi yao xing ye xie hui shang hai yi yao za zhi she ju ban zhi yao ji xie ji shu yu fu wu lun tan

..............page:62-62

shang hai yi yao za zhi ju ban yan suan zuo lun xi ping yao wu zhi liao zhuan jia yan tao hui

..............page:31-31

Application of angiotensin-converting enzyme inhibitors in coronary artery disease
ZHOU Yanli;LI Xinli

..............page:7-9

Analysis of value-based medicine pricing mechanism in UK
MAO Yangdui;CHANG Feng

..............page:32-35

Progress of renin-angiotensin system inhibitors in the treatment of hypertension
TAO Rong

..............page:10-13

fda qiang hua a pian lei yao wu biao qian de jing gao xin xi
zhai zi ding xiang yuan

..............page:62-62

yi yao wu liu she hui hua fa zhan de tan suo
hong ping

..............page:22-24

The selection of antihypertensive drugs in diabetes
RUAN Jingming;ZHOU Jingmin

..............page:14-18

Optimization of preparation and formulation of the sustained-release pellets of disodium clodronate
HUANG Zhan;WANG Jing;GUO Yuzhi;WANG Xi

..............page:36-37,38

Determination of bilirubin content in Xiao’er Huadu Powder by colorimetry
ZENG Xiaojuan;MA FuJia;SI Xiaoli

..............page:43-45

Application of macroporous resin in the extraction and puriifcation of traditional Chinese medicine
WU Juan;TIAN Lulu;ZHU Deqiu

..............page:46-49

Antimicrobial peptides-potential alternatives to antibiotics
CAI Jing

..............page:55-57,58

2013 nian 8 yue fda pi zhun xin yao gai kuang

..............page:60-60,61

guo jia zhong yi ju yin fa er ji yi yuan gai jin xi ze
bei jing shang bao

..............page:45-45

fda jing gao hui rui qi xia ti jia huan su zeng jia huan zhe de si wang feng xian
zhai zi ding xiang yuan

..............page:61-61,62

Application of angiotensin-converting enzyme inhibitors and angiotensinⅡreceptor blockers in chronic kidney disease
LIN Pan;LIU Hong

..............page:3-6

fda pi zhun abraxane wan qi yi xian ai xin shi ying zheng
zhai zi ding xiang yuan

..............page:61-61

Logistics management model of hospital drugs under the background of new medical reform
JI Min;XI Yumin;WU Tao

..............page:25-26,27